A detailed history of Baird Financial Group, Inc. transactions in Incyte Corp stock. As of the latest transaction made, Baird Financial Group, Inc. holds 144,137 shares of INCY stock, worth $10.3 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
144,137
Previous 123,508 16.7%
Holding current value
$10.3 Million
Previous $7.49 Million 27.25%
% of portfolio
0.02%
Previous 0.02%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$57.33 - $68.61 $1.18 Million - $1.42 Million
20,629 Added 16.7%
144,137 $9.53 Million
Q2 2024

Aug 13, 2024

SELL
$51.18 - $63.75 $1.95 Million - $2.43 Million
-38,079 Reduced 23.57%
123,508 $7.49 Million
Q1 2024

May 14, 2024

SELL
$56.55 - $66.59 $6 Million - $7.06 Million
-106,047 Reduced 39.62%
161,587 $9.21 Million
Q4 2023

Feb 14, 2024

BUY
$52.16 - $64.19 $725,284 - $892,561
13,905 Added 5.48%
267,634 $16.8 Million
Q3 2023

Nov 13, 2023

SELL
$57.77 - $65.93 $877,584 - $1 Million
-15,191 Reduced 5.65%
253,729 $14.7 Million
Q2 2023

Aug 11, 2023

BUY
$60.95 - $75.51 $3.23 Million - $4 Million
52,942 Added 24.51%
268,920 $16.7 Million
Q1 2023

May 15, 2023

SELL
$70.23 - $86.01 $1.39 Million - $1.71 Million
-19,860 Reduced 8.42%
215,978 $15.6 Million
Q3 2022

Nov 14, 2022

SELL
$66.18 - $82.86 $809,712 - $1.01 Million
-12,235 Reduced 5.02%
231,321 $15.4 Million
Q2 2022

Aug 08, 2022

SELL
$66.18 - $83.18 $1.4 Million - $1.76 Million
-21,143 Reduced 7.99%
243,556 $18.5 Million
Q1 2022

May 13, 2022

SELL
$66.02 - $79.71 $613,061 - $740,187
-9,286 Reduced 3.39%
264,699 $21 Million
Q4 2021

Feb 09, 2022

BUY
$63.34 - $74.11 $2.13 Million - $2.49 Million
33,587 Added 13.97%
273,985 $20.1 Million
Q3 2021

Nov 12, 2021

BUY
$68.67 - $84.02 $2.48 Million - $3.03 Million
36,054 Added 17.64%
240,398 $16.5 Million
Q2 2021

Aug 11, 2021

BUY
$79.87 - $87.53 $2.18 Million - $2.38 Million
27,235 Added 15.38%
204,344 $17.2 Million
Q1 2021

May 13, 2021

BUY
$76.02 - $100.5 $1.72 Million - $2.27 Million
22,581 Added 14.61%
177,109 $14.4 Million
Q4 2020

Feb 11, 2021

BUY
$80.74 - $97.7 $1.76 Million - $2.13 Million
21,817 Added 16.44%
154,528 $13.4 Million
Q3 2020

Nov 12, 2020

BUY
$85.07 - $109.69 $7.75 Million - $9.99 Million
91,109 Added 219.0%
132,711 $11.9 Million
Q2 2020

Oct 22, 2020

BUY
$74.18 - $108.93 $133,375 - $195,856
1,798 Added 4.52%
41,602 $191,000
Q2 2020

Aug 14, 2020

BUY
$74.18 - $108.93 $358,437 - $526,349
4,832 Added 13.82%
39,804 $4,000
Q1 2020

May 14, 2020

BUY
$63.18 - $85.97 $506,324 - $688,963
8,014 Added 29.73%
34,972 $2.56 Million
Q4 2019

Feb 14, 2020

SELL
$73.04 - $95.72 $818,340 - $1.07 Million
-11,204 Reduced 29.36%
26,958 $2.35 Million
Q3 2019

Nov 14, 2019

BUY
$72.82 - $86.52 $44,201 - $52,517
607 Added 1.62%
38,162 $49,000
Q2 2019

Aug 14, 2019

BUY
$73.52 - $88.7 $27,790 - $33,528
378 Added 1.02%
37,555 $3.19 Million
Q1 2019

May 14, 2019

SELL
$63.56 - $88.17 $397,504 - $551,415
-6,254 Reduced 14.4%
37,177 $3.2 Million
Q4 2018

Feb 14, 2019

SELL
$58.5 - $69.94 $839,709 - $1 Million
-14,354 Reduced 24.84%
43,431 $2.76 Million
Q3 2018

Nov 13, 2018

BUY
$61.75 - $74.23 $1,605 - $1,929
26 Added 0.05%
57,785 $3.99 Million
Q2 2018

Aug 13, 2018

BUY
$60.85 - $83.98 $1.7 Million - $2.34 Million
27,886 Added 93.35%
57,759 $3.87 Million
Q1 2018

May 14, 2018

BUY
$83.06 - $100.98 $398,771 - $484,804
4,801 Added 19.15%
29,873 $2.49 Million
Q4 2017

Feb 09, 2018

BUY
$93.56 - $116.6 $924,934 - $1.15 Million
9,886 Added 65.1%
25,072 $2.38 Million
Q3 2017

Nov 14, 2017

SELL
$109.15 - $138.27 $33,727 - $42,725
-309 Reduced 1.99%
15,186 $1.77 Million
Q2 2017

Aug 14, 2017

BUY
N/A
15,495
15,495 $1.95 Million

Others Institutions Holding INCY

About INCYTE CORP


  • Ticker INCY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 222,431,008
  • Market Cap $16B
  • Description
  • Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...
More about INCY
Track This Portfolio

Track Baird Financial Group, Inc. Portfolio

Follow Baird Financial Group, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Baird Financial Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Baird Financial Group, Inc. with notifications on news.